Drawing for BIOAPATITE

USPTO serial 74565209

BIOAPATITE

Reviewed by CopyMark Law Group

Reg. 2078277Status 710
Filing date
Status date
Registration date
Jul 15, 1997
Examiner
CASE, LEIGH CAROLINE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIOAPATITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael B. Lasky

MICHAEL B LASKY MERCHANT, GOULD, SMITH, EDELL, ET AL3100 NORWEST CTR90 S 7TH STMINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical and veterinary preparations, namely, carrying agents for pharmaceutical and veterinary drugs and nutritional agents in the nature of nutritional supplements for oral, rectal, topical and parenteral use; chemical diagnostic reagents for pharmaceutical and veterinary purposes; artificial saliva for pharmaceutical and veterinary purposes; micro-encapsulated liquid crystals for use as delivery systems for pharmaceutical and veterinary products; dietary supplements for medical use; medical plasters; all purpose disinfectants; carrying agents for pharmaceutical and veterinary drugs for bone regenerationSECTION 8 - CANCELLED
010artificial formable bone matrix for human or animal bone replacement or reconstruction of bone tissueSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 17, 2004C8..CANCELLED SEC. 8 (6-YR)
Jul 15, 1997R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 22, 1997PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 21, 1997NPUBNOTICE OF PUBLICATION
Feb 10, 1997CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 19971.BDSec. 1(B) CLAIM DELETED
Jan 6, 1997CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 1996CNSLLETTER OF SUSPENSION MAILED
Jun 27, 1996CNEAEXAMINER'S AMENDMENT MAILED
Apr 1, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 1995CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 1995CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 24, 1995DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance